HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry.

Abstract
Extensive cross-reactivity in T cell receptor (TCR) recognition of peptide-MHC (pMHC) complexes seems to be essential to give sufficient immune surveillance against invading pathogens. This carries with it an inherent risk that T cells activated during a response to clear an infection can, perhaps years later, respond to a self pMHC of sufficient similarity. This lies at the heart of the molecular mimicry theory. Here we discuss our studies on the disease-causing potential of altered peptide ligands (APL) based on the sequence of a single autoantigenic epitope, the Ac1-9 peptide of myelin basic protein that induces experimental autoimmune encephalomyelitis in mice. These show that the window of similarity to self for induction of disease by cross-reactive non-self peptides is actually quite restricted. We show that each of the three pillars of immune tolerance (death, anergy/adaptation and regulation) has a role in limiting the risk of molecular mimicry by maintaining a threshold for harm.
AuthorsKelli R Ryan, Sarju D Patel, Leigh A Stephens, Stephen M Anderton
JournalJournal of autoimmunity (J Autoimmun) Vol. 29 Issue 4 Pg. 262-71 (Dec 2007) ISSN: 0896-8411 [Print] England
PMID17870412 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Autoantibodies
  • Autoantigens
  • Receptors, Antigen, T-Cell
Topics
  • Adaptation, Physiological (immunology)
  • Animals
  • Autoantibodies (immunology)
  • Autoantigens (immunology)
  • Autoimmune Diseases
  • Autoimmunity
  • Cell Death
  • Humans
  • Immune Tolerance
  • Infections (immunology)
  • Molecular Mimicry
  • Receptors, Antigen, T-Cell (immunology)
  • T-Lymphocytes (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: